An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

NCT07543120 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
323
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals